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Abstract
Background: 1α,25-Dihydroxyvitamin D [1,25(OH)2 vitD] is 
the bioactive form of vitamin D. Due to the very low con-
centrations of 1,25(OH)2 vitD in the blood and its lipophilic 
character, measurement of this parameter is analytically 
challenging. Requiring preceding manual extraction steps 
before analysis, previous assays have been laborious.
Methods: In the presented study, we evaluated the per-
formance of two immunoassays from DiaSorin and from 
Immunodiagnostic Systems (IDS) which combine fully 
automated extraction and measurement of 1,25(OH)2 
vitD. Imprecision and linearity were verified according 
to Clinical and Laboratory Standards Institute EP15-A3 
and EP6-A guidelines, respectively. Ninety-three patient 
serum samples sent to our institute for determination of 
1,25(OH)2 vitD, as well as 20 Vitamin D External Quality 
Assessment Scheme (DEQAS) samples, were used to eval-
uate correlation and agreement of 1,25(OH)2 vitD measure-
ments between the two immunoassays and with liquid 
chromatography coupled to tandem mass spectrometry 
(LC-MS/MS).
Results: Total imprecision was 5.2% or less for the DiaSorin 
test but reached 20.1% for the IDS iSYS test. 1,25(OH)2 vitD 
concentrations measured with the DiaSorin assay showed 
a strong correlation with 1,25(OH)2 vitD levels measured 
by LC-MS/MS and a good agreement with method specific 
means of DEQAS samples. By contrast, the IDS iSYS test 
overestimated 1,25(OH)2 vitD concentrations in human 
serum, particularly at higher concentrations.
Conclusions: Due to its high sensitivity, low imprecision, 
broad measurement range, and good agreement with 
1,25(OH)2 vitD concentrations measured by LC-MS/MS, the 
DiaSorin test is a valuable analytical option for the deter-
mination of 1,25(OH)2 vitD.
Keywords: 1α,25-dihydroxyvitamin D; immunoassay; 
method comparison; serum.
Introduction
1α,25-Dihydroxyvitamin D [1,25(OH)2 vitD], the active form 
of vitamin D, is synthesized by mitochondrial 25-hydroxy-
vitamin D-1α-hydroxylase in the kidney and in extrarenal 
tissues. In addition to the kidney, particularly disease-
activated tissue macrophages and the placenta may con-
tribute to circulating concentrations of 1,25(OH)2 vitD 
[1]. 1,25(OH)2 vitD mediates actions generally ascribed to 
vitamin D including the absorption of calcium and phos-
phorus from the intestine, the retention of calcium from 
the kidney and bone mineralization, thereby preventing 
rickets and osteomalacia. Recently observed associations 
of low vitamin D levels with increased risks of cardio-
vascular diseases [2–4], type 2 diabetes [5], autoimmune 
diseases [6], infections of the upper respiratory tract 
[7], neurodegenerative disease [8], as well as breast or 
colorectal cancer [9, 10] point to extraskeletal actions of 
vitamin D. The expanded knowledge of the relevance of 
sufficient vitamin D levels is reflected by an experienced 
increased demand for the determination of vitamin D 
status in patients.
Although 1,25(OH)2 vitD is less suitable than 
25-hydroxyvitamin D [25(OH) vitD] to assess vitamin D 
status, there are some indications to specifically deter-
mine 1,25(OH)2 vitD serum levels. This mainly includes 
differential diagnosis of hypercalcemia in patients with 
sarcoidosis and other granulomatous diseases. Deter-
mination of 1,25(OH)2 vitD can also be useful in patients 
with unexplained hyperparathyroidism who have ade-
quate 25(OH) vitD levels. 1,25(OH)2 vitD is particularly 
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suitable to differentiate between two hereditary defects 
namely vitamin D-dependent rickets (VDDR) type I, 
caused by vitamin D 1α-hydroxylase deficiency, and 
VDDR type II, caused by mutation of the vitamin D recep-
tor gene leading to end-organ resistance to vitamin D. 
The growing knowledge of the prognostic significance 
of 1,25(OH)2 vitD after cardiac surgery and in sepsis and 
heart failure [11–13] will further increase the medical need 
to analyze 1,25(OH)2 vitD.
Due to its low concentration (pmol/L) and lipophilic 
nature, the quantification of 1,25(OH)2 vitD in serum is 
analytically challenging and requires extraction and 
separation steps prior to measurement. So far, mainly 
radioimmunoassays have been used for the measurement 
of 1,25(OH)2 vitD. They measure this parameter with suf-
ficient sensitivity but are laborious, time consuming and 
prone to laboratory error associated with manual handling 
of the probes. The first automated assay including manual 
extraction had been developed by Immunodiagnostic 
Systems (IDS) Ltd., using the IDS iSYS immunoanalyzer. 
Recently, two assays became commercially available, 
which include not only the automated measurement but 
also an automated extraction of 1,25(OH)2 vitD prior to 
quantification. In this study, we evaluated and compared 
the performance of these two fully automated assays with 
each other and with liquid chromatography coupled to 
tandem mass spectrometry (LC-MS/MS).
The measurement of 1,25(OH)2 vitD is poorly standard-
ized. Whereas for the standardization of 25(OH) vitD meas-
urements, a reference measurement procedure as well as 
National Institute of Standards and Technology standard 
reference material is available [14, 15], for 1,25(OH)2 vitD, 
a lot of work remains to be done to render the results 
from different laboratories and methods comparable. The 
Vitamin D External Quality Assessment Scheme (DEQAS) 
supports this standardization process by providing exter-
nal quality control material not only for 25(OH) vitD but 
also for 1,25(OH)2 vitD. We therefore compared the values 
measured using the fully automated assays with the 
results obtained by DEQAS.
Materials and methods
Samples
Remaining material of 142 patient serum samples submitted to the 
Institute of Clinical Chemistry of the University Hospital Zurich for 
routine measurement of 1,25(OH)2 vitD was aliquoted and stored at 
− 80 °C until analysis. All samples with extensive hemolysis, biliru-
binemia or lipemia were excluded from the study. For analysis with 
the different tests, serum samples were thawed and one aliquot 
each was analyzed according to the manufacturer’s instructions. Of 
93 samples, sufficient serum material was available for measurement 
of 1,25(OH)2 vitD concentrations using a LC-MS/MS based method.
Only samples of patients aged 18 years or older were included 
in the study. The study has been approved by the Zurich Cantonal 
Ethical Committee.
Immunoassays
Serum samples were measured with the LIAISON XL 1,25 Dihydroxy-
vitamin D assay (DiaSorin, Stillwater, MN, USA) on the LIAISON 
XL platform and with the IDS-iSYS 1,25 VitDXp assay (IDS, Boldon, 
UK) on the IDS-iSYS Multi-Discipline Automated System. Both tests 
are chemiluminescence-immunoassays and both tests capture the 
analyte from the probe prior to measurement of analyte concentra-
tion. Whereas the DiaSorin test uses a recombinant fusion protein 
to capture 1,25(OH)2 vitD from the probe [16], the IDS test uses anti-
1,25(OH)2 vitD antibody coated magnetic particles for immunopurifi-
cation. After several washing steps, the purified analyte is measured 
by an immunoassay. The DiaSorin test determines the 1,25(OH)2 vitD 
concentration directly after addition of the conjugate and a starter 
reagent to induce the light reaction [16]. The resulting signal is 
directly proportional to the analyte concentration. The IDS test, in 
contrast, uses a competitive immunoassay for detection of 1,25(OH)2 
vitD concentration, where a certain concentration of an 1,25(OH)2 
vitD acridinium conjugate competes for the binding sites of a bioti-
nylated sheep anti-1,25(OH)2 vitD antibody. Thus, the resulting signal 
is inversely proportional to the amount of the analyte in the probe.
The performance characteristics of the immunoassays are out-
lined in Table 1.
Mass spectrometry
For measurement of 1,25(OH)2 vitD with LC-MS/MS, aliquots were 
shipped on dry ice to the laboratory of Prof. Hoofnagle at the Univer-
sity of Washington (Seattle, WA, USA). 1,25(OH)2 vitD2 and 1,25(OH)2 
vitD3  serum concentrations were measured there as previously 
described [17].
Imprecision and accuracy
Assay imprecision has been estimated according to Clinical and 
Laboratory Standards Institute (CLSI) EP15-A3 guidelines [18]. Manu-
facturers’ quality control material as well as patient serum samples 
have been analyzed over 5 days with five measurements a day. From 
the obtained 25 measurements, within-run, between-run, and total 
imprecision have been estimated.
Linearity 
Serial dilutions of a sample with high 1,25(OH)2 vitD concentration 
have been prepared using serum with very low or even non-meas-
ureable low levels as diluent in order to cover the measurement 
range of the tests. 1,25(OH)2 vitD concentrations were determined in 
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duplicates and measured serum concentrations were compared to 
expected concentrations. Polynomial regression analysis has been 
used for the assessment of linearity according to the National Com-
mittee on Clinical Laboratory Standards (NCCLS) EP6-A evaluation 
protocol [19]. A linear or non-linear coefficient was assumed to be 
statistically significant if p was < 0.05.
Method comparison
Frozen aliquots were thawed and equilibrated to room temperature. 
Samples were mixed gently and analyzed in batches on the IDS 
iSYS and the LIAISON XL immunoanalyzer. Quality control sam-
ples were analyzed together with each batch of samples to monitor 
the performance of the assays and the instruments. Correlation and 
agreement between the tested methods were assessed by means of 
Passing-Bablok regression analysis [20], Bland-Altman difference 
plots [21], and determination of Pearson’s coefficient of correlation. 
For correlation analysis, samples below the lower limit of the meas-
urement range were assigned the value of the lower limit (7.5 and 5.0 
ng/L for the IDS test and the DiaSorin test, respectively).
Statistical analysis
All statistical analyses were performed using Analyse-it, a statistical 
software for Microsoft Excel (Analyse-it Software Ltd.)
Results
Imprecision and accuracy
For the determination of imprecision, quality control 
material available from the respective manufacturer as 
well as human serum pools were analyzed according to 
the CLSI EP15-A3 guidelines. Imprecision results from 
a total of 25  measurements of each probe are shown in 
Table 2.
The DiaSorin test determined 1,25(OH)2 vitD very pre-
cisely, with total imprecision ranging between 3.1% and 
5.2% and hence within the range of 3.6%–6.6% reported 
by the manufacturer. In contrast, the total imprecision of 
the IDS test ranged between 7.1% and 20.1%. Intra- and 
inter-assay imprecisions were between 5.6% and 19.8% 
and between 3.5% and 15.3%, respectively, as compared to 
intra-assay and inter-assay imprecisions reported by the 
manufacturer, being 6.4%–12.1% and 4.6%–9.6%, respec-
tively. However, for the imprecision determined by the 
manufacturer, only serum samples with concentrations 
of 25.3 ng/L and above have been investigated. Further-
more, we found that the DiaSorin test measured 1,25(OH)2 
vitD concentrations with better accuracy than the IDS 
test, namely with a bias of 2.5% and − 0.1% as compared 
to 21.3% and 14.1%.
Linearity
A series of dilutions was prepared by adding different 
amounts of serum with very low or non-measurable low 
1,25(OH)2 vitD concentrations to a serum sample with 
high 1,25(OH)2 vitD concentrations. Within the measure-
ment ranges either test showed good correlations between 
measured and expected 1,25(OH)2 vitD concentrations 
(Figure 1). Statistical analysis revealed that none of the 
non-linear coefficients was statistically significant. Thus, 
Table 1: Assay specifications of the two commercial assays for determination of 1,25(OH)2 vitD used in this study.
Assay LIAISON XL 1,25 Dihydroxyvitamin D assay IDS-iSYS 1,25 VitDXp assay
Analyzer LIAISON XL IDS iSYS
Principle CLIA with prior extraction CLIA with prior extraction
Extraction of 1,25(OH)2 vitD Recombinant fusion protein Anti-1,25(OH)2 vitD antibody
Antibody used for 1,25(OH)2 vitD determination Mouse, monoclonal Sheep, monoclonal
Label Luminol Acridinium
Measuring range 5.0–200.0 ng/L 7.5–210.0 ng/L
LoQ 5.0 ng/L Not given
Needed amount of serum 225 μL (75 μL + 150 μL dead volume) 400 μL (220 μL + 180 μL dead volume)
Cross reactivity
 1,25(OH)2 vitD3 100% (100 ng/L) 98% (conc. not given)
 1,25(OH)2 vitD2 104% (100 ng/L) 57% (conc. not given)
 25(OH) vitD3 < 0.1% (100,000 ng/L) 0.0014% (conc. not given)
 25(OH) vitD2 < 0.1% (50,000 ng/L) 0.0005% (conc. not given)
 24,25(OH)2 vitD3 < 0.1% (50,000 ng/L) 0.0005% (conc. not given)
 24,25(OH)2 vitD2 < 0.1% (50,000 ng/L) 0.041% (conc. not given)
 3-epi25(OH) vitD3 < 0.1% (50,000 ng/L) 0.0005% (conc. not given)
Data derived from package inserts provided by the manufacturers. CLIA, chemiluminescence immunoassay; LoQ, limit of quantification.
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for the IDS test as well as the DiaSorin test a linear equa-
tion models the data best. Reflecting the high imprecision, 
the IDS test showed poorer agreement between duplicate 
measurements.
Method comparisons
Correlation and agreement between the immunoassays
One hundred forty-two serum samples, sent for routine 
analysis of 1,25(OH)2 vitD to our institute, were measured 
with both, the LIAISON XL 1,25 Dihydroxyvitamin D assay 
and the IDS-iSYS 1,25 VitDXp assay (for correlation see 
Supplementary Figure 1). In the 93 patient samples with 
sufficient material for measurement with either method, 
the immunoassays and LC-MS/MS, 1,25(OH)2 vitD concen-
trations ranged from < 7.5 to 202.5 ng/L if measured with 
the IDS test, from < 5.0 to 126.0 ng/L if measured with the 
DiaSorin test, and from 3.0 to 118.6 ng/L if measured by 
LC-MS/MS. 1,25(OH)2 vitD concentrations measured with 
the IDS test tended to be higher than those measured with 
the DiaSorin assay (Figure 2A). This was most pronounced 
in the higher concentration range (above about 40 ng/L) as 
indicated by the respective Bland-Altman-Plot (Figure 2B). 
Over the whole measurement range, the scattering of the 
values was high as reflected by the 95% limits of agreement 
of the bias ( ± 1.96*standard deviation [SD]): Bland-Altman 
analysis revealed a mean bias of 4.9%, the lower and upper 
limits of agreement were − 67.5% and 77.4%, respectively.
Correlation and agreement of the immunoassays with 
the LC-MS/MS method
To check for accuracy, results obtained by the two immu-
noassays on 93 patient samples were compared with the 
results obtained by LC-MS/MS, a method propagated as the 
reference method for 1,25(OH)2 vitD measurement. Com-
pared to the IDS test, the DiaSorin measurement results 
showed stronger correlations with the LC-MS/MS results 
(r = 0.852, Figure 2C vs. r = 0.967, Figure 2E). Moreover, the 
IDS test overestimated 1,25(OH)2 vitD serum concentrations 
especially in the higher concentration range, whereas the 
DiaSorin test showed good agreement. In the Bland-Alt-
man analysis mean bias was 7.0% (95% LoA, − 69.8% and 
83.9%) for the IDS test but only 2.3% (95% LoA, − 29.2% 
and 33.7%) for the DiaSorin test (Figure 2D, F).
Unlike the immunoassays, LC-MS/MS can distinguish 
between 1,25(OH)2 vitD2 and 1,25(OH)2 vitD3. The majority 
of the samples had very low 1,25(OH)2 vitD2 levels, only 
6 of the 93  samples with total 1,25(OH)2 vitD concentra-
tions between 7.8 and 85.1 ng/L measured with LC-MS/MS 
contained 5% or more 1,25(OH)2 vitD2. One of these 
Table 2: Imprecision and inaccuracy of the IDS iSYS and the DiaSorin LIAISON XL- 1,25(OH)2 vitD assays.
Sample Human Serum Control 1 Control 2
Pool 1 Pool 2 Pool 3 Pool 4
IDS iSYS
 Mean concentration, ng/L 14.4 27.3 108.1 43.2 88.6
 Target concentration, ng/L (range) 35.6 (18.5–52.7) 77.7 (49.7–105.7)
 Bias, ng/L 7.6 10.9
 Bias, % 21.3 14.1
 Imprecision, %
  Total (within laboratory) 20.1 18.9 7.1 15.9 8.9
  Within run (repeatability) 19.8 11.1 5.8 7.5 5.6
  Between run 3.5 15.3 4.1 14.0 7.0
DiaSorin LIAISON XL
 Mean concentration, ng/L 8.5 13.0 29.8 91.9 31.2 121.9
 Target concentration, ng/L (range) 30.4 (21.9–38.9) 122.0 (92.8–151)
 Bias, ng/L 0.8 − 0.1
 Bias, % 2.5 − 0.1
 Imprecision, %
  Total (within laboratory) 4.4 5.2 4.1 3.1 4.5 3.3
  Within run (repeatability) 2.5 4.4 3.7 1.5 3.5 2.5
  Between run 3.6 2.8 1.8 2.7 2.9 2.1
For measurement of imprecision in human serum human serum pools were used. Controls 1 + 2: quality control material level 1 and 2 of the 
respective test. There were no statistical outliers as tested by Grubbs’ test.
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 26.06.17 10:24
Spanaus and von Eckardstein: Evaluation of automated 1,25-dihydroxyvitamin D immunoassays      5
Figure 1: Assessment of method linearity for the IDS iSYS and the DiaSorin 1,25(OH)2 vitD assay.
For evaluation of the IDS test a serum sample with a mean concentration of 188.2 ng/L 1,25(OH)2 vitD was diluted with a serum sample with 
a 1,25(OH)2 vitD concentration below the detection limit of the test. For the DiaSorin test a serum probe containing 188.5 ng/L 1,25(OH)2 vitD 
was diluted with serum with a 1,25(OH)2 vitD concentration of 5.8 ng/L. Statistical analysis was performed according to the NCCLS EP6-A 
evaluation protocol.
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samples had a 1,25(OH)2 vitD concentration below the 
detection limit when measured with the IDS test and was 
therefore excluded from statistical analysis for this test. 
The 1,25(OH)2 vitD concentrations of the samples with 
1,25(OH)2 vitD2 concentrations between 5.8% and 76.6% 
of total 1,25(OH)2 vitD showed a mean deviation of 86.7 
Figure 2: Method comparison of the two fully automated immunoassays and a LC-MS based method for measurement of 1,25(OH)2 vitD.
Left panel: Passing-Bablok regression analysis of the IDS with the DiaSorin test (A) and the IDS (C) and the DiaSorin test (E), respectively, 
with LC-MS as a reference method. The bold red solid line represents the regression line, the fine grey line represents the line of equality. 
Right panel: Bland-Altman plots for comparison of the IDS with the DiaSorin assay (B) and the IDS (D) and the DiaSorin assay (F), respec-
tively, with LC-MS. The bold blue solid line indicates the relative mean bias, the dashed blue lines represent the upper and lower limit of 
agreement, respectively.
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 26.06.17 10:24
Spanaus and von Eckardstein: Evaluation of automated 1,25-dihydroxyvitamin D immunoassays      7
(IDS) and 98.2% (DiaSorin) from 1,25(OH)2 vitD3 measured 
by LC-MS/MS, but of only 3.7 (IDS) and 1.2% (DiaSorin), 
respectively, when compared to the sum of 1,25(OH)2 vitD2 
and 1,25(OH)2 vitD3. This suggests nearly complete cross-
reactivity of either immunoassay with 1,25(OH)2 vitD2.
Performance in external quality control 
measurements
To date, no international standard is available for the 
measurement of 1,25(OH)2 vitD. To compensate for this 
lack, we measured 20  samples from DEQAS, the largest 
vitamin D quality assessment program worldwide, with 
the two novel immunoassays to compare our measure-
ments with the results of other laboratories (Table 3). 
Seventy-five percent and 95% of results measured by the 
IDS test and the DiaSorin test, respectively, are within 1 SD 
of the method specific mean. None of our results showed 
deviations of 2 or more SDs from the method mean. Thus, 
measurements in our laboratory are comparable to the 
results obtained by other laboratories using the IDS iSYS 
or the DiaSorin test.
Both immunoassays showed a good agreement of the 
quality control sample measurements with LC-MS/MS. 
Mean deviations of the IDS and DiaSorin measurement 
results from the mean of LC-MS/MS measurements were 
2.1% and 1.8%, respectively. However, individual meas-
urements with the IDS test deviated more strongly from 
the LC-MS/MS method (range, − 51% to 50%) than meas-
urements with the DiaSorin test (− 20% to 26%), reflect-
ing the higher imprecision of the IDS test as seen in the 
method comparison and the imprecision study (Figure 3).
Discussion
In the presented study, we evaluated the analytical perfor-
mance of two new commercially available fully automated 
assays for the measurement of 1,25(OH)2 vitD. Both immu-
noassays allow for determination of 1,25(OH)2 vitD within 
a shorter time frame compared to radioimmunoassays and 
other tests with manual sample pretreatment. Overall, the 
DiaSorin test performed better in terms of accuracy, sensi-
tivity and imprecision compared to the IDS iSYS test.
The DiaSorin test running on the LIAISON XL ana-
lyzer measured 1,25(OH)2 vitD with good sensitivity and 
high reliability. Precision was very good even in the low 
concentration range and comparable to precision values 
previously described. Van Helden and Weiskirchen 
Table 3: Immunoassay measurement results and method means and standard deviations of DEQAS samples.
DEQAS 
sample ID
 
 
IDS iSYS 
 
DiaSorin 
 
LC-MS/MS
Measurement 
Value, ng/L
  Method mean 
(SD)b, ng/L
  na Measurement 
Value, ng/L
  Method mean 
(SD)b, ng/L
  na Method mean 
(SD)b, ng/L
  na
351   19.3  22.6 (6.2)  32  21.0  22.8 (4.6)  17  25.1 (7.0)  13
352   43.5  42.6 (7.3)  32  38.8  37.3 (7.7)  17  41.6 (13.1)  13
353   70.8  64.6 (10.4)  32  52.7  52.6 (9.7)  17  55.4 (22.0)  13
354   69.8  61.8 (9.7)  32  49.7  48.1 (8.0)  17  46.3 (13.1)  13
355   58.8  58.7 (7.7)  32  57.3  53.5 (9.0)  17  49.9 (15.5)  13
361   37.8  37.3 (8.9)  35  37.8  35.7 (4.8)  47  38.0 (8.2)  13
362   28.9  25.8 (6.3)  35  30.8  24.9 (3.3)  47  29.6 (7.5)  13
363   55.2  48.6 (9.2)  35  43.5  43.3 (4.8)  47  45.0 (8.0)  13
364   65.8  52.8 (9.3)  35  51.6  47.2 (5.0)  47  44.5 (8.1)  13
365   37.1  32.3 (6.5)  35  37.2  34.6 (3.8)  47  32.7 (6.0)  13
371   24.2  32.5 (7.3)  37  34.2  29.8 (5.0)  74  38.0 (5.5)  14
372   60.7  60.9 (10.1)  37  55.2  52.6 (8.1)  74  52.0 (9.8)  14
373   29.7  37.2 (8.9)  37  37.1  36.0 (5.2)  74  36.0 (7.2)  14
374   58.8  67.1 (11.5)  37  55.4  51.5 (7.4)  74  59.4 (18.8)  14
375   45.0  47.9 (9.2)  37   58.0  60.0 (7.9)  74  46.0 (19.1)  14
376   47.9  64.6 (13.5)  36  64.6  62.6 (6.7)  70  54.2 (6.3)  14
377   44.9  53.2 (10.3)  36  48.3  48.4 (5.5)  70  49.4 (7.2)  14
378   11.5  18.5 (5.7)  36  18.4  17.7 (2.8)  70  23.1 (9.8)  14
379   42.5  47.4 (9.6)  36  45.4  47.3 (5.3)  70  41.5 (7.3)  14
380   31.7  43.0 (9.2)  36  29.9  31.4 (4.2)  70  34.5 (9.9)  14
an, number of participants; bSD, standard deviation.
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measured 1,25(OH)2 vitD in control material and serum 
pools with concentrations between 22.1 and 184.7 ng/L 
and found a repeatability and intermediate precision 
between 1.0%–5.0% and 3.8%–7.1%, respectively [16]. In a 
different study, intra- and inter-assay imprecision ranged 
from 1.1% to 4.7% and from 3.4% to 7.2%, respectively, in 
controls and serum pools with concentrations between 
25.5 and 180.4  ng/L [22]. As we demonstrate here, the 
DiaSorin test measures 1,25(OH)2 vitD very precisely even 
at concentrations < 10 ng/L. Furthermore, 1,25(OH)2 vitD 
concentrations measured with this test showed a very 
good correlation and agreement with 1,25(OH)2 vitD levels 
determined with the LC-MS/MS reference method.
The IDS assay with automated extraction running 
on the IDS iSYS immunoanalyzer measured 1,25(OH)2 
vitD less precisely compared to the DiaSorin test. At 
concentrations of 14.4 ng/L total imprecision amounted 
to 20%. The limit of detection as indicated by the manu-
facturer is 7.5 ng/L for the IDS test. Even the limit of quan-
tification of 5.0 ng/L for the DiaSorin test is lower than 
the IDS detection limit, reflecting the high imprecision of 
the IDS test.
Furthermore, compared to the DiaSorin test, 1,25(OH)2 
vitD concentrations measured with the IDS test showed 
weaker correlations and poorer agreement with those 
measured by LC-MS/MS. Both the comparison with 
LC-MS/MS measurements and the measurement of DEQAS 
quality controls revealed that the IDS test underestimates 
1,25(OH)2 vitD concentrations below 40 ng/L and overes-
timates higher concentrations. IDS test results deviated 
from the LC-MS/MS method mean of DEQAS by − 50% 
to + 51% compared to − 20% to + 26% deviations of the 
DiaSorin test.
The two methods apply different fully automated 
extraction procedures prior to the measurement of 
1,25(OH)2 vitD. Whereas the DiaSorin test uses a recom-
binant fusion protein to capture 1,25(OH)2 vitD, the IDS 
test purifies the analyte from the serum using an anti-
1,25(OH)2 vitD antibody. One might argue that the fusion 
protein binds to 1,25(OH)2 vitD with higher specificity 
than the antibody, leading to the lower imprecision and 
the better correlation with LC-MS/MS of the DiaSorin 
test. However, our currently used IDS test with manual 
extraction of 1,25(OH)2 vitD shows significantly stronger 
correlation with the LC-MS/MS measurements than the 
fully automated IDS test (r = 0.908 vs. r = 0.852, Figure 4), 
although this was still weaker than that of the DiaSorin 
test (r = 0.967). Assuming that the same antibody is 
used for the manual and automated extraction prior to 
Figure 4: Method comparison of the IDS test using manual immunopurification of 1,25(OH)2 vitD with LC-MS analysis.
Left panel (A): Passing-Bablok regression analysis. The bold red solid line represents the regression line, the fine grey line represents the 
line of equality. Right panel (B): Bland-Altman plot. The bold blue solid line indicates the relative mean bias, the dashed blue lines represent 
the upper and lower limit of agreement, respectively.
Figure 3: Relative deviation of 1,25(OH)2 vitD concentrations 
measured with the IDS iSYS and the DiaSorin 1,25(OH)2 vitD assay, 
respectively, from LC-MS/MS method mean in DEQAS samples.
The blue rhombs represent IDS values, grey squares represent the 
concentrations measured with the DiaSorin test.
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measurement of 1,25(OH)2 vitD, the automated extraction 
steps of the IDS test need to be optimized.
1,25-Dihydroxyvitamin D2 is derived from dietary 
ergocalciferol, which is subsequently 25-hydroxylated 
in the liver and 1α-hydroxylated in the kidney. Both, 
vitamins D2 and D3 are comparably biologically active 
[23]. In order to correctly represent the biologically rel-
evant amounts, the tests used for the determination of 
1,25(OH)2 vitD should measure either form. The LC-MS/
MS method used in our study differentiates between D2 
and D3. Of the six serum samples with 1,25(OH)2 vitD2 
concentrations above 5% of total 1,25(OH)2 vitD, five 
samples contained amounts between 1.3 and 8.3 ng/L, 
most likely due to a high content of vegetable food and/or 
due to substitution. In one patient with a total 1,25(OH)2 
vitD concentration of 29.7 ng/L, the 1,25(OH)2 vitD2 pro-
portion amounted to 76.6%. Since we did not have any 
information about lifestyle or medication, the reason for 
the high 1,25(OH)2 vitD2 level in this particular patient 
remains unclear. When we compared the 1,25(OH)2 vitD 
concentrations measured with the immunoassays versus 
LC-MS/MS results in samples with significant amounts of 
1,25(OH)2 vitD2, we found a mean deviation of 3.7% and 
1.2% for the IDS test and the DiaSorin test, respectively. 
Thus, we assume that both tests almost completely 
cross-react with 1,25(OH)2 vitD2. This is in accordance 
with the manufacturer’s data for the DiaSorin test. For 
the IDS test, a cross-reactivity of 57% is indicated by the 
manufacturer, but the respective tested concentration 
is not indicated. In our study, we only had six samples 
with 1,25(OH)2 vitD2 concentrations above 5% of total 
1,25(OH)2 vitD. Further studies involving more samples 
with significantly  elevated 1,25(OH)2 vitD2 levels are 
necessary to precisely evaluate the cross-reactivity of 
the tests with 1,25(OH)2 vitD2. No or only very low cross-
reactivity is indicated by either manufacturer for vitamin 
D metabolites with less biological activity.
Measurement of 1,25(OH)2 vitD using fully auto-
mated tests is of significant advantage, particularly as 
the number of samples submitted for the determination 
of this parameter has increased over the recent years. The 
implementation of such tests allows for higher through-
put and less hands-on time compared to the manual 
tests used so far. Together with the high sensitivity, low 
imprecision, the broad measurement range and the good 
agreement with 1,25(OH)2 vitD concentrations measured 
with LC-MS/MS, the DiaSorin test improves 1,25(OH)2 
vitD diagnostics. The fully automated test performed on 
the IDS iSYS has a comparable broad measurement range 
but needs further improvement with respect to sensitivity, 
precision and standardization. The respective limitations 
have most recently been addressed by the supplier by a 
further development of the test, for which the presented 
study will serve as an ideal starting point and framework 
for the evaluation of critical performance factors.
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